Daniel Markwardt
Impact in
- Hepatology top 1%
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
-
- Acute Kidney Injury Research
Papers in
-
- Liver Disease and Transplantation 6
- Hepatocellular Carcinoma Treatment and Prognosis 1
- Oncology 3
- PARP inhibition in cancer therapy 1
- COVID-19 and healthcare impacts 1
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Alexander L. Gerbes (4 shared papers)Christian J. Steib (3 shared papers)Jonel Trebicka (1 shared paper)Daniel Teupser (1 shared paper)Elisabet García (1 shared paper)Lesca Miriam Holdt (1 shared paper)Vicente Arroyo (1 shared paper)Mauro Bernardi (1 shared paper)
In The Last Decade
Daniel Markwardt
9 papers receiving 754 citations
Daniel Markwardt's Hit Papers
Peers
Comparison fields: 5 of 47
- Hepatology 676
- Nephrology 31
- Applied Microbiology and Biotechnology 7
- Epidemiology 37
- Pathology and Forensic Medicine 18
Countries citing papers authored by Daniel Markwardt
This map shows the geographic impact of Daniel Markwardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Markwardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Markwardt more than expected).
Fields of papers citing papers by Daniel Markwardt
This network shows the impact of papers produced by Daniel Markwardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Markwardt. The network helps show where Daniel Markwardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Markwardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology Hit paper breakdown → | 2020 | 369 |
| 2 | 2020 | 233 | |
| 3 | 2017 | 84 | |
| 4 | 2022 | 34 | |
| 5 | 2020 | 15 | |
| 6 | 2019 | 14 | |
| 7 | 2019 | 10 | |
| 8 | 2022 | 3 | |
| 9 | 2023 | 3 | |
| 10 | 2025 | 0 |
About Daniel Markwardt
Daniel Markwardt is a scholar working on Hepatology, Oncology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 10 papers that have together received 765 indexed citations. Recurring topics across this work include Liver Disease and Transplantation (6 papers), PARP inhibition in cancer therapy (1 paper), COVID-19 and healthcare impacts (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Hepatology (676 citations), Nephrology (31 citations), Applied Microbiology and Biotechnology (7 citations), Epidemiology (37 citations) and Pathology and Forensic Medicine (18 citations). Daniel Markwardt has collaborated with scholars based in Germany, Spain and Italy. Frequent co-authors include Alexander L. Gerbes, Christian J. Steib, Jonel Trebicka, Daniel Teupser, Elisabet García, Lesca Miriam Holdt, Vicente Arroyo, Mauro Bernardi, Richard Moreau and Frederik Nevens. Their work appears in journals such as Journal of Hepatology, Medical Oncology, Digestive and Liver Disease, JCO Precision Oncology and European Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.